2 terminated, 1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Cota Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MYnd Analytics Directed Therapy in Depression MYnd Analytics PEER Online directed antidepressant therapy, Conventional antidepressant therapy - Depression | Phase 4 | Unknown | Cota Inc. | 600 | 2017-10-01 | 2017-11-06 |
| Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers NantHealth GPS Cancer Test - Pancreatic Cancer, Metastatic Breast Cancer | Terminated | Cota Inc. | 40 | 2017-02-28 | 2018-07-20 | |
| Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer Genomic profile by FoundationOne, Genomic profile by other methods - Carcinoma, Non-small Cell Lung | Terminated | Cota Inc. | 649 | 2015-04-01 | 2018-07-20 |
Lung Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Depression (1) · Melanoma (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1)
United States (3)
Deena Atieh Graham, MD (1) · Martin Gutierez, MD (1) · Ramon Solhkhah, MD (1)